The results of the clinical study published in the Journal of Medicinal Foods, include statistically significant improvement in joint stiffness and performance in the 6-minute walk test. Five times less stiffness was reported in BiovaFlex subjects over placebo. Subjects also reported feeling improvement after five days on a regimen of 450 mg of BiovaFlex daily.
“The completion and publication of this study validates the five-day results we saw in our previous joint care clinical and continues to enhance the body of research supporting our proprietary products,” said Pat Schneider, CEO, Biova LLC.
Biova will be presenting the results of the study at SupplySide West in the Supplier Presentation Theater on Thursday, Oct. 17 at 11 am.